François Le Loarer Selected Research

Disease Progression

11/2023

Translational Aspects of Epithelioid Sarcoma - Current Consensus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Le Loarer Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 04/2012
20	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 11/2017
4	Tertiary Lymphoid Structures 01/2024 - 10/2022
3	Liposarcoma 10/2020 - 11/2017
3	Rhabdomyosarcoma 01/2020 - 01/2020
2	Fibrosarcoma 03/2023 - 06/2022
2	Giant Cell Tumors (Giant Cell Tumor) 01/2023 - 01/2020
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2019 - 01/2019
2	Aggressive Fibromatosis (Desmoid) 01/2019 - 04/2012
2	Arthritis (Polyarthritis) 01/2015 - 12/2012
1	Disease Progression 11/2023
1	Melanoma (Melanoma, Malignant) 08/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Margins of Excision 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Mesenchymal Chondrosarcoma 10/2020
1	Myxoid Liposarcoma 06/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Giant Cell Tumor of Bone 01/2020
1	Neutropenia 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Dermatofibrosarcoma 11/2018
1	Necrosis 11/2017

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2012
6	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2020
5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2021
4	MyogeninIBA 12/2023 - 01/2019
3	Keratins (Keratin)IBA 11/2021 - 01/2020
3	AnthracyclinesIBA 01/2021 - 11/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 10/2022
2	avelumabIBA 01/2024 - 01/2021
2	Trinitrotoluene (TNT)IBA 08/2023 - 04/2017
2	Phosphotransferases (Kinase)IBA 03/2023 - 06/2022
2	pembrolizumabIBA 10/2022 - 01/2020
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 06/2022 - 11/2018
2	DesminIBA 11/2021 - 01/2021
2	erdafitinibIBA 12/2020 - 10/2020
2	Aggrecans (Aggrecan)IBA 10/2020 - 10/2020
2	LigandsIBA 01/2020 - 12/2012
2	Imatinib Mesylate (Gleevec)FDA Link 08/2019 - 01/2019
2	palbociclibIBA 08/2019 - 01/2019
2	Sunitinib (Sutent)FDA Link 08/2019 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 12/2012
1	Inhibins (Inhibin)IBA 12/2023
1	Complementary DNA (cDNA)IBA 10/2023
1	Estrogens (Estrogen)FDA Link 10/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2023
1	CollagenIBA 10/2023
1	AntigensIBA 08/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	Co-Repressor ProteinsIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	Toll-Like Receptor 4IBA 10/2022
1	Tyrosine (L-Tyrosine)FDA Link 06/2022
1	AntibodiesIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	InterferonsIBA 01/2022
1	ParaffinIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	regorafenibIBA 01/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	monomethyl auristatin EIBA 03/2020
1	Immunoconjugates (Immunoconjugate)IBA 03/2020
1	atezolizumabIBA 01/2020
1	berzosertibIBA 01/2020
1	navoximodIBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Denosumab FDA Link 01/2020
1	Gemcitabine FDA Link 01/2020
1	ChromatinIBA 01/2020
1	EnzymesIBA 01/2020
1	KynurenineIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	CytokinesIBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2019
1	GadoliniumIBA 02/2019
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2019
1	Vinyl Chloride (Chloroethylene)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	pazopanib FDA Link 01/2019
1	DioxinsIBA 01/2019
1	ChlorophenolsIBA 01/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 11/2018
1	alpha 1 Chain Collagen Type IIBA 11/2018
1	TrabectedinIBA 11/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2017
1	rucaparibIBA 11/2017

Therapy/Procedure

6	Therapeutics 01/2024 - 04/2017
6	Drug Therapy (Chemotherapy) 11/2023 - 11/2017
6	Neoadjuvant Therapy 01/2022 - 12/2018
2	Aftercare (After-Treatment) 10/2022 - 01/2019
2	Immunotherapy 01/2022 - 01/2020
2	Radiotherapy 06/2020 - 01/2020
2	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 04/2017
1	Ligation 01/2022
1	Precision Medicine 03/2019